Navigation Links
Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement
Date:12/23/2009

rnalLink');" target='_blank' href="http://www.kowapharma.com/">www.kowapharma.com.

About Lilly

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com. C-LLY

This news release contains forward-looking statements. These statements are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made. Factors that might cause such a difference include, among others, Lilly and Kowa' abilities to successfully commercialize and market Livalo, competition from other pharmaceutical companies (including generic versions of other statin products), potential regulatory developments affecting the product, and other factors described in Lilly's most recent filings with the Securities and Exchange Commission. For additional information about the factors that affect the company's business, please see Lilly's latest Form 10-K, filed February 2009, and Form 10-Q filed October 2009. Lilly undertakes no duty to update forward-looking statements.

LIVALO® (pitavastatin, Kowa Pharmaceuticals America Inc.)

Lipitor® (atorvastatin, Pfizer Inc.)

Zocor® (simvastatin, Merck and Co., Inc)

Pravachol® (pravastatin, Bristol-Myers Squibb Company)

SOURCE Eli Lilly and Company


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 2014 /PRNewswire-iReach/ -- Use of Risk Evaluation and Mitigation ... generic market entry results in $5.4 billion in lost ... analysis by economic consulting firm Matrix Global ... Required by the Food and Drug ... programs are intended to improve drug safety by ensuring ...
(Date:7/23/2014)...  When it comes to welcoming our new robot overlords, ... out the red carpet. Healthcare is one of ... robots into our human sphere. With healthcare concerns top of ... to apply new technologies to help with old problems. That,s ... is expected to increase from $1.7 billion now to $3.7 ...
(Date:7/23/2014)... , July 23, 2014  Nearly 8,000 attendees will ... Cardinal Health,s annual Retail Business Conference (RBC), taking place ... Center. This year,s event encourages pharmacists to "Lead Change" ... communities and for their future. ... to network with their peers and learn new ways ...
Breaking Medicine Technology:New Analysis Finds $5.4 Billion In Annual Lost Savings From Strategies Geared Toward Delaying Generic Drug Entry 2Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 2Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 3Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 4Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 5Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 6
... Telik, Inc. (Nasdaq: TELK ) today ... Research (AACR) Annual Meeting in Orlando, Florida on a ... clinically advanced product in development at Telik.  Ezatiostat is ... validated enzyme target in Myelodysplastic Syndrome (MDS), to successfully ...
... YONKERS, N.Y., April 5, 2011 New drugstore Ratings published ... available online at www.ConsumerReportsHealth.org reveal that the overwhelming ... at neighborhood independent drugstores. While customers said they were generally ... and lagging service at some big box stores. ...
Cached Medicine Technology:Telik Announces Presentation of New Data on the Characterization of Novel Ezatiostat (TELINTRA®, TLK199) Analogs at American Association for Cancer Research Annual Meeting 2Telik Announces Presentation of New Data on the Characterization of Novel Ezatiostat (TELINTRA®, TLK199) Analogs at American Association for Cancer Research Annual Meeting 3Telik Announces Presentation of New Data on the Characterization of Novel Ezatiostat (TELINTRA®, TLK199) Analogs at American Association for Cancer Research Annual Meeting 4Consumer Reports' Drugstore Ratings: 94% of Shoppers "Highly Satisfied" With Independents; Some Irked By Long Waits at Big Box Stores 2Consumer Reports' Drugstore Ratings: 94% of Shoppers "Highly Satisfied" With Independents; Some Irked By Long Waits at Big Box Stores 3Consumer Reports' Drugstore Ratings: 94% of Shoppers "Highly Satisfied" With Independents; Some Irked By Long Waits at Big Box Stores 4
(Date:7/23/2014)... supports a growing body of research suggesting a ... in treating postmenopausal breast cancer, with fewer detrimental ... standard anti-hormone therapies. The study will be published ... Reproductive Biology and Endocrinology . , Breast ... women in the United States. Approximately 70% of ...
(Date:7/23/2014)... Global Cardio Care, Inc., a management company ... is celebrating the 100th birthday of Albert Weber, ... center. , Weber has been plagued with angina ... therapy since 1999, he no longer suffers from either ... Cardio Care, introduced the Sara Soulati Health For ...
(Date:7/23/2014)... The voice on the recording was low and calm as ... was infected with the human immunodeficiency virus (HIV) that causes AIDS: ... you know I was on the floor flat on my face ... when the recording ended less than 10 minutes later. “Don’t feel ... because it is just God setting you up for something greater,” ...
(Date:7/23/2014)... For patients infected with both HIV and hepatitis C, ... a small study suggests. Researchers said doctors could ... with the two diseases. "The findings suggest ... role in the management of individuals with [hepatitis C] ... a professor of medicine at the University of Cincinnati ...
(Date:7/23/2014)... Texas Physical Therapy Specialists (TexPTS) is ... Westlake, Westgate, Liberty Hill, Parmer, Balcones, and Georgetown clinics ... Orthopaedic Certified Specialist (OCS) or Sports ... DPT, OCS, Tony Lauretta, PT, DPT, OCS, Jason Brown, ... Leech, PT, DPT, OCS, and Mary Grimberg, PT, DPT, ...
Breaking Medicine News(10 mins):Health News:Hormones after breast cancer: Not fuel for the fire after all? 2Health News:Hormones after breast cancer: Not fuel for the fire after all? 3Health News:Hormones after breast cancer: Not fuel for the fire after all? 4Health News:Hormones after breast cancer: Not fuel for the fire after all? 5Health News:Global Cardio Care Celebrates EECP Patient’s 100th Birthday 2Health News:HIV clinic-based audio project emphasizes the power of patient voices 2Health News:HIV clinic-based audio project emphasizes the power of patient voices 3Health News:HIV Meds May Also Help Control Hepatitis C, Study Finds 2Health News:Texas Physical Therapy Specialists Congratulates New Board Certified Specialists 2Health News:Texas Physical Therapy Specialists Congratulates New Board Certified Specialists 3
... urge more awareness that long-term use has consequences , ... and other cardiovascular problems appear to be more common ... androgen deprivation therapy, which reduces or eliminates the male ... study has found. , The finding indicates that androgen ...
... Tamiflu Oral Suspension ... ... (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has begun shipping additional quantities of ... begin arriving in pharmacies nationwide and will continue to roll out to wholesale and retail ...
... The following is an op-ed written by Fredette West, Director, African ... how can the nation can pay for health reform; and in ... all the talk about finding "off-sets" -- media, legislators, and analysts, ... studies from Johns Hopkins University and the University of Maryland. A ...
... Initiates Training Program Partnering with Healthcare Employers , WEST ... a $134,790 grant by the State of Florida to fund ... for skilled health care workers in Palm Beach County. ... Healthcare Workforce Initiative. The funding enables Workforce Alliance to ...
... can,t teach an old dog new tricks," it,s often said. ... to be passed down from generation to generation. , "While some ... them and act on them," says Mark Nunez, DVM, president of ... veterinarian to find out if a commonly held belief is really ...
... ― Two medications approved as treatment for drug-resistant chronic ... responses as a first treatment than the existing front-line ... Anderson Cancer Center reported at the 51st Annual Meeting ... for CML remains imatinib, a Novartis drug known as ...
Cached Medicine News:Health News:Prostate Hormone Therapy May Up Heart Risks 2Health News:Prostate Hormone Therapy May Up Heart Risks 3Health News:Roche Announces Shipments of New Supplies of Children's Tamiflu in the U.S. 2Health News:Roche Announces Shipments of New Supplies of Children's Tamiflu in the U.S. 3Health News:Roche Announces Shipments of New Supplies of Children's Tamiflu in the U.S. 4Health News:Roche Announces Shipments of New Supplies of Children's Tamiflu in the U.S. 5Health News:Health Reform is About You and Me, Not One or the Other 2Health News:Health Reform is About You and Me, Not One or the Other 3Health News:Workforce Alliance Earns Grant to Train Health Care Workers 2Health News:Workforce Alliance Earns Grant to Train Health Care Workers 3Health News:Some Myths About Dogs and Cats Are Not Only False - They're Dangerous! 2Health News:Second-line CML drugs evoke faster response than front-line therapy 2
VascoScrew is a unipolar permanent pacing lead with a fixed screw a double flanch for permanent pacing. Due to latest technologies, VascoScrew D10/60 M is compatible to all pacemaker-cavities with th...
VascoScrew is a unipolar permanent pacing lead with a fixed screw a double flanch for permanent pacing. Due to latest technologies, VascoScrew D10/60 M is compatible to all pacemaker-cavities with th...
VascoTwist is a low profile unipolar permanent pacing lead with a retractable screw. Due to advanced technology VascoTwist 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
Medicine Products: